CD1d-independent activation of invariant natural killer T cells by Staphylococcal enterotoxin B through major histocompatibility complex class II/T cell receptor interaction results in acute lung injury

Infection and Immunity

Volumn 79, Issue 8, 2011, Pages 3141-3148

  Rieder, Sadiye Amcaoglu ^a   Nagarkatti, Prakash ^a   Nagarkatti, Mitzi ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAPHYLOCOCCUS ENTEROTOXIN B; T LYMPHOCYTE RECEPTOR;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE STORM; FEMALE; IN VITRO STUDY; MONONUCLEAR CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ACUTE LUNG INJURY; ANIMALS; ANTIGENS, CD1D; CAPILLARY PERMEABILITY; CYTOKINES; ENTEROTOXINS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL;

EID: 79961119915     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00177-11     Document Type: Article

References (37)

1. Akbari, O., et al. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9:582-588.
2. Arrenberg, P., R. Halder, and V. Kumar. 2009. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens. J. Cell. Physiol. 218:246-250.
3. Baker, M. D., and K. R. Acharya. 2004. Superantigens: structure-function relationships. Int. J. Med. Microbiol. 293:529-537.
4. Balato, A., D. Unutmaz, and A. A. Gaspari. 2009. Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. J. Invest. Dermatol. 129:1628-1642.
5. Berzins, S. P., M. J. Smyth, and D. I. Godfrey. 2005. Working with NKT cells-pitfalls and practicalities. Curr. Opin. Immunol. 17:448-454.
6. Boyton, R. 2008. The role of natural killer T cells in lung inflammation. J. Pathol. 214:276-282.
7. Florquin, S., and L. Aaldering. 1997. Superantigens: a tool to gain new insight into cellular immunity. Res. Immunol. 148:373-386.
8. Guan, H., P. S. Nagarkatti, and M. Nagarkatti. 2007. Blockade of hyaluronan inhibits IL-2-induced vascular leak syndrome and maintains effectiveness of IL-2 treatment for metastatic melanoma. J. Immunol. 179:3715-3723.
9. Henghold, W. B., 2nd. 2004. Other biologic toxin bioweapons: ricin, staphylococcal enterotoxin B, and trichothecene mycotoxins. Dermatol. Clin. 22: 257-262.
10. Huzella, L. M., M. J. Buckley, D. A. Alves, B. G. Stiles, and T. Krakauer. 2009. Central roles for IL-2 and MCP-1 following intranasal exposure to SEB: a new mouse model. Res. Vet. Sci. 86:241-247.
11. Iwamura, C., and T. Nakayama. 2007. Role of α-galactosylceramide-activated Vα14 natural killer T cells in the regulation of allergic diseases. Allergol. Int. 56:1-6.
12. Krakauer, T. 2005. Chemotherapeutics targeting immune activation by staphylococcal superantigens. Med. Sci. Monit. 11:RA290-RA295.
13. Krakauer, T., M. J. Buckley, L. M. Huzella, and D. A. Alves. 2009. Critical timing, location and duration of glucocorticoid administration rescue mice from superantigen-induced shock and attenuate lung injury. Int. Immunopharmacol. 9:1168-1174.
14. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23:877-900.
15. Kronenberg, M., and I. Engel. 2007. On the road: progress in finding the unique pathway of invariant NKT cell differentiation. Curr. Opin. Immunol. 19:186-193.
16. Kronenberg, M., and Y. Kinjo. 2009. Innate-like recognition of microbes by invariant natural killer T cells. Curr. Opin. Immunol. 21:391-396.
17. Lee, P. K., G. M. Vercellotti, J. R. Deringer, and P. M. Schlievert. 1991. Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells. J. Infect. Dis. 164:711-719.
18. Lutz, M. B., et al. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92.
19. Marrack, P., M. Blackman, E. Kushnir, and J. Kappler. 1990. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med. 171:455-464.
20. Matsuda, J. L., T. Mallevaey, J. Scott-Browne, and L. Gapin. 2008. CD1drestricted iNKT cells, the "Swiss-Army knife" of the immune system. Curr. Opin. Immunol. 20:358-368.
21. McKallip, R. J., et al. 2003. Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by interleukin-2-activated cytolytic lymphocytes. J. Biol. Chem. 278:43818-43830.
22. + T regulatory cells in IL-2-induced vascular leak. Int. Immunol. 18:1461-1471.
23. Mercer, J. C., M. J. Ragin, and A. August. 2005. Natural killer T cells: rapid responders controlling immunity and disease. Int. J. Biochem. Cell Biol. 37:1337-1343.
24. Metelitsa, L. S., et al. 2001. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J. Immunol. 167:3114-3122.
25. Nagarajan, N. A., and M. Kronenberg. 2007. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 178:2706-2713.
26. Newell, K. A., J. D. Ellenhorn, D. S. Bruce, and J. A. Bluestone. 1991. In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor. Proc. Natl. Acad. Sci. U. S. A. 88:1074-1078.
27. Notas, G., T. Kisseleva, and D. Brenner. 2009. NK and NKT cells in liver injury and fibrosis. Clin. Immunol. 130:16-26.
28. Rafi, A. Q., et al. 1998. Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome. J. Immunol. 161:3077-3086.
29. Rafi-Janajreh, A. Q., et al. 1999. Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. J. Immunol. 163:1619-1627.
30. Ragin, M. J., N. Sahu, and A. August. 2006. Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure. Infect. Immun. 74:282-288.
31. Singh, A. K., et al. 2001. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194:1801-1811.
32. Strandberg, K. L., et al. 2010. Staphylococcal superantigens cause lethal pulmonary disease in rabbits. J. Infect. Dis. 202:1690-1697.
33. Taniguchi, M., K. Seino, and T. Nakayama. 2003. The NKT cell system: bridging innate and acquired immunity. Nat. Immunol. 4:1164-1165.
34. Tumurkhuu, G., et al. 2008. The mechanism of development of acute lung injury in lethal endotoxic shock using alpha-galactosylceramide sensitization. Clin. Exp. Immunol. 152:182-191.
35. van der Vliet, H. J., et al. 2004. The immunoregulatory role of CD1d-restricted natural killer T cells in disease. Clin. Immunol. 112:8-23.
36. Van Kaer, L. 2005. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat. Rev. Immunol. 5:31-42.
37. Van Kaer, L. 2007. NKT cells: T lymphocytes with innate effector functions. Curr. Opin. Immunol. 19:354-364.